Literature DB >> 10628488

Embolization coils as tumor markers for mammography in patients undergoing neoadjuvant chemotherapy for carcinoma of the breast.

M P Braeuning1, E T Burke, E D Pisano.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10628488     DOI: 10.2214/ajr.174.1.1740251

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  4 in total

1.  Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy.

Authors:  Julia L Oh; Giang Nguyen; Gary J Whitman; Kelly K Hunt; Tse-Kuan Yu; Wendy A Woodward; Welela Tereffe; Eric A Strom; George H Perkins; Thomas A Buchholz
Journal:  Cancer       Date:  2007-12-01       Impact factor: 6.860

2.  The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

Authors:  O Burgués; Mª Á López-García; B Pérez-Míes; P Santiago; B Vieites; J F García; V Peg
Journal:  Clin Transl Oncol       Date:  2017-08-09       Impact factor: 3.405

3.  Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.

Authors:  William G Cance; Lisa A Carey; Benjamin F Calvo; Carolyn Sartor; Lynda Sawyer; Dominic T Moore; Julian Rosenman; David W Ollila; Mark Graham
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

Review 4.  Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

Authors:  V Bossuyt; E Provenzano; W F Symmans; J C Boughey; C Coles; G Curigliano; J M Dixon; L J Esserman; G Fastner; T Kuehn; F Peintinger; G von Minckwitz; J White; W Yang; S Badve; C Denkert; G MacGrogan; F Penault-Llorca; G Viale; D Cameron
Journal:  Ann Oncol       Date:  2015-05-27       Impact factor: 32.976

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.